Quick Answer
STAAR SURGICAL CO reported Total Revenue of $239.44 million for fiscal year 2025.
STAAR SURGICAL CO — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $239.44M -23.7% |
$313.90M -2.6% |
$322.42M +34.7% |
$239.44M +3.9% |
$230.47M +41.0% |
$163.46M +8.8% |
| Net Income | -$80.45M -298.1% |
-$20.21M -194.7% |
$21.35M -46.2% |
$39.66M +44.2% |
$27.51M +365.3% |
$5.91M -57.9% |
| Diluted EPS | -$1.62 -295.1% |
-$0.41 -195.3% |
$0.43 -46.2% |
$0.80 +42.9% |
$0.56 +366.7% |
$0.12 -60.0% |
| Total Assets | $451.68M -11.4% |
$509.52M +4.3% |
$488.69M +16.7% |
$418.82M +21.1% |
$345.78M +34.3% |
$257.42M +24.0% |
| Cash and Equivalents | $153.15M +6.2% |
$144.16M -21.2% |
$183.04M +111.7% |
$86.48M -56.7% |
$199.71M +31.0% |
$152.45M +27.1% |
| Stockholders Equity | $344.18M -13.4% |
$397.33M +2.9% |
$385.95M +14.8% |
$336.11M +28.5% |
$261.57M +32.6% |
$197.22M +23.4% |
| R&D Expense | $40.05M -11.6% |
$45.32M +12.0% |
$40.48M +12.5% |
$35.98M +6.3% |
$33.86M +6.1% |
$31.92M +26.2% |
| Operating Income | -$91.71M -627.2% |
-$12.61M -144.9% |
$28.10M -35.9% |
$43.80M +31.4% |
$33.34M +392.5% |
$6.77M -42.9% |
| Gross Profit | $182.42M -23.9% |
$239.58M -5.2% |
$252.65M +13.1% |
$223.38M +25.0% |
$178.64M +50.9% |
$118.36M +5.7% |
| Shares Outstanding | 49.40M +0.2% |
49.29M +0.9% |
48.84M +1.3% |
48.21M +1.0% |
47.72M +2.6% |
46.49M +3.7% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $94.73M | +6.9% | +113.7% |
| Net Income | September 30, 2025 | $8.88M | -11.0% | +152.8% |
| Diluted EPS | September 30, 2025 | $0.18 | -10.0% | +152.9% |
| Total Assets | September 30, 2025 | $456.36M | -15.1% | +4.2% |
| Cash and Equivalents | September 30, 2025 | $176.16M | +7.4% | +5.4% |
| Stockholders Equity | September 30, 2025 | $353.78M | -17.4% | +5.1% |
| R&D Expense | September 30, 2025 | $9.21M | -24.8% | -10.3% |
| Operating Income | September 30, 2025 | $18.49M | +225.4% | +161.7% |
| Gross Profit | September 30, 2025 | $77.88M | +13.7% | +137.4% |
| Shares Outstanding | September 30, 2025 | 49.73M | +0.9% | +0.4% |
- STAAR SURGICAL CO reported Total Revenue of $239.44 million for fiscal year 2025.
- STAAR SURGICAL CO showed a decrease of -23.7% in Total Revenue compared to the prior fiscal year.
- STAAR SURGICAL CO reported Net Income of -$80.45 million for fiscal year 2025.
- STAAR SURGICAL CO showed a decrease of -298.1% in Net Income compared to the prior fiscal year.
- STAAR SURGICAL CO reported Diluted EPS of $1.62 per share (loss) for fiscal year 2025.
- STAAR SURGICAL CO showed a decrease of -295.1% in Diluted EPS compared to the prior fiscal year.
- STAAR SURGICAL CO reported Total Assets of $451.68 million for fiscal year 2025.
- STAAR SURGICAL CO showed a decrease of -11.4% in Total Assets compared to the prior fiscal year.
- STAAR SURGICAL CO reported Cash and Equivalents of $153.15 million for fiscal year 2025.
- STAAR SURGICAL CO showed an increase of +6.2% in Cash and Equivalents compared to the prior fiscal year.
- STAAR SURGICAL CO reported Stockholders Equity of $344.18 million for fiscal year 2025.
- STAAR SURGICAL CO showed a decrease of -13.4% in Stockholders Equity compared to the prior fiscal year.
- STAAR SURGICAL CO reported R&D Expense of $40.05 million for fiscal year 2025.
- STAAR SURGICAL CO showed a decrease of -11.6% in R&D Expense compared to the prior fiscal year.
- STAAR SURGICAL CO reported Operating Income of -$91.71 million for fiscal year 2025.
- STAAR SURGICAL CO showed a decrease of -627.2% in Operating Income compared to the prior fiscal year.
- STAAR SURGICAL CO reported Gross Profit of $182.42 million for fiscal year 2025.
- STAAR SURGICAL CO showed a decrease of -23.9% in Gross Profit compared to the prior fiscal year.
- STAAR SURGICAL CO reported Shares Outstanding of 49.40 million shares for fiscal year 2025.
- STAAR SURGICAL CO showed an increase of +0.2% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: